Total Payments
$11,080
2024 Payments
$738.72
Companies
29
Transactions
789
Medicare Patients
1,350
Medicare Billing
$141,527
Payment Breakdown by Category
Food & Beverage$10,825 (97.7%)
Education$254.90 (2.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $10,825 | 779 | 97.7% |
| Education | $254.90 | 10 | 2.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,885 | 100 | $0 (2024) |
| Alkermes, Inc. | $1,537 | 72 | $0 (2024) |
| Lundbeck LLC | $956.51 | 178 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $868.71 | 53 | $0 (2024) |
| ITI, Inc. | $854.75 | 52 | $0 (2023) |
| Allergan, Inc. | $795.58 | 57 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $757.52 | 58 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $750.84 | 44 | $0 (2022) |
| ABBVIE INC. | $558.84 | 50 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $516.40 | 40 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $738.72 | 20 | Alkermes, Inc. ($220.87) |
| 2023 | $1,986 | 115 | ITI, Inc. ($419.16) |
| 2022 | $1,236 | 81 | ITI, Inc. ($233.29) |
| 2021 | $636.25 | 60 | Alkermes, Inc. ($189.34) |
| 2020 | $1,072 | 70 | Lundbeck LLC ($231.28) |
| 2019 | $2,043 | 170 | Otsuka America Pharmaceutical, Inc. ($466.99) |
| 2018 | $1,954 | 163 | Otsuka America Pharmaceutical, Inc. ($332.20) |
| 2017 | $1,413 | 110 | Otsuka America Pharmaceutical, Inc. ($338.32) |
All Payment Transactions
789 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), ABILIFY ASIMTUFII | Food and Beverage | In-kind items and services | $97.31 | General |
| Category: PSYCHIATRY | ||||||
| 11/13/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $49.46 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $61.75 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $83.69 | General |
| Category: CNS | ||||||
| 10/09/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Education | In-kind items and services | $27.27 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $39.50 | General |
| Category: NEUROSCIENCE | ||||||
| 09/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: Central Nervous System | ||||||
| 06/05/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Neuropsychiatry | ||||||
| 05/22/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $62.82 | General |
| Category: CNS | ||||||
| 05/03/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Psychology/Psychiatric | ||||||
| 04/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.72 | General |
| Category: PSYCHIATRY | ||||||
| 04/11/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $54.61 | General |
| Category: CNS | ||||||
| 03/26/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.85 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.04 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: PSYCHIATRY | ||||||
| 03/07/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $1.35 | General |
| Category: PSYCHIATRY | ||||||
| 03/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: CNS | ||||||
| 02/05/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: PSYCHIATRY | ||||||
| 01/23/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $57.08 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 01/03/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Central Nervous System | ||||||
| 12/20/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $25.13 | General |
| Category: PSYCHIATRY | ||||||
| 12/18/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $26.52 | General |
| Category: PSYCHIATRY | ||||||
| 12/15/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/14/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.55 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 272 | 752 | $50,121 | $31,440 |
| 2022 | 3 | 306 | 820 | $55,064 | $34,298 |
| 2021 | 2 | 341 | 927 | $62,350 | $40,561 |
| 2020 | 4 | 431 | 1,074 | $71,352 | $35,228 |
Total Patients
1,350
Total Services
3,573
Medicare Billing
$141,527
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 251 | 728 | $48,441 | $30,907 | 63.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 21 | 24 | $1,680 | $532.68 | 31.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 280 | 790 | $52,567 | $33,016 | 62.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 12 | 15 | $1,499 | $967.61 | 64.6% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 15 | $998.42 | $314.22 | 31.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 324 | 907 | $60,352 | $39,174 | 64.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 20 | $1,998 | $1,387 | 69.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 358 | 1,000 | $66,841 | $33,093 | 49.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 32 | $3,197 | $1,790 | 56.0% |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | Office | 2020 | 29 | 29 | $403.68 | $188.30 | 46.6% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $910.00 | $155.51 | 17.1% |
About Dr. Donald Atkinson, MD
Dr. Donald Atkinson, MD is a Psychiatry healthcare provider based in Cookeville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/01/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205938446.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Donald Atkinson, MD has received a total of $11,080 in payments from pharmaceutical and medical device companies, with $738.72 received in 2024. These payments were reported across 789 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($10,825).
As a Medicare-enrolled provider, Atkinson has provided services to 1,350 Medicare beneficiaries, totaling 3,573 services with total Medicare billing of $141,527. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Cookeville, TN
- Active Since 09/01/2006
- Last Updated 03/07/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1205938446
Products in Payments
- REXULTI (Drug) $1,563
- VRAYLAR (Drug) $1,354
- CAPLYTA (Drug) $1,011
- ABILIFY MAINTENA (Drug) $931.82
- INGREZZA (Drug) $868.71
- LATUDA (Drug) $757.52
- ARISTADA (Drug) $640.76
- Fanapt (Drug) $532.36
- INVEGA SUSTENNA (Drug) $325.40
- LYBALVI (Drug) $262.40
- Aristada 441 mg (Drug) $259.83
- HETLIOZ (Drug) $218.48
- BRINTELLIX (Drug) $216.82
- Trintellix (Drug) $168.12
- AUSTEDO (Drug) $154.82
- INVEGA TRINZA (Drug) $144.71
- Vivitrol 380 mg (Drug) $142.94
- VIVITROL (Drug) $129.51
- TRINTELLIX (Drug) $122.66
- Azstarys (Drug) $114.38
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.